SecBot SecBot
8-K ·Filed May 5, 2026

AZTA

Azenta, Inc.
BEARISH
Impact 8/10
Horizonimmediate Processed6mo ago SEC0001628280-26-030677
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

Expect sharp downside pressure as guidance cuts confirm deteriorating demand and execution. Monitor the May 6 earnings call for details on cost actions and B Medical sale timeline. The lack of buyback execution despite authorization suggests management priorities elsewhere.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$18.38
T+0 close · May 5, 2026 · via day close
Latest settled
+53.05%
T+60 · $28.13
Vs SPY
+50.99%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 6 $18.38entry
  2. T+1 · 6mo ago +1.03%α +1.36% · $18.57
  3. T+5 · 6mo ago −4.62%α −5.76% · $17.53
  4. T+20 · 6mo ago +29.98%α +27.20% · $23.89
  5. T+60 · 4mo ago +53.05%α +50.99% · $28.13

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Azenta reported Q2 FY2026 revenue of $145M (+1% reported, -3% organic), non-GAAP EPS of ($0.04) vs $0.01 a year ago, and a $149M goodwill impairment. FY2026 guidance was sharply cut: organic revenue now expected -2% to +1% (prior 3-5% growth) and Adjusted EBITDA margin expected -125bps to flat (prior +300bps expansion). Long-range plan extended to 2029, and B Medical Systems sale remains uncertain. The filing signals worsening demand and execution issues.

Key Financial Metrics

EPS
−$0.04
Revenue
$145.0M
+1.0% YoY
Rating
strong miss
Guidance
$603M-$621M
lowered
Free Cash Flow
$5.0M
Gross Margin
42.8%

Key Facts

  • Q2 FY2026 revenue: $145M, up 1% YoY reported, organic down 3%
  • GAAP diluted EPS from continuing ops: ($3.41) vs ($0.43) YoY, including $149M goodwill impairment
  • Non-GAAP diluted EPS: ($0.04) vs $0.01 YoY
  • FY2026 organic revenue guidance lowered to -2% to +1% from prior 3-5% growth
  • FY2026 Adjusted EBITDA margin outlook cut to -125bps to flat from prior +300bps expansion
  • Long-range plan extended from 2028 to 2029
  • B Medical Systems sale delayed; buyer has not secured financing
  • No share repurchases executed under $250M program

Financial Impact

Goodwill impairment of $149M; guidance revision implies $30-40M revenue reduction vs prior outlook

revenueepsebitdagoodwill

Risk Factors

  • Further demand weakening in life sciences tools market
  • B Medical Systems sale falling through, requiring additional cash outflows or write-downs
  • Additional impairment charges if revenue trends continue declining
  • Dilution from potential equity offering if cash needs arise

Market Snapshot

Exchange
Nasdaq
Sector
Special Industry Machinery, NEC
Analyst Consensus
64% bullish (14 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-030677
Document: azta-20260505.htm0001628280-26-030677
Document: 0001628280-26-030677-index-headers.html0001628280-26-030677
Document: 0001628280-26-030677-index.html0001628280-26-030677
Document: 0001628280-26-030677.txt0001628280-26-030677
8-K Data (Synthetic)0001628280-26-030677

Track record

12 reports on AZTA

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 10, 20266d ago 8-K Bullish 6/10 Entry $48.90 Now $47.22 −3.44% settles Nov 18
  2. Oct 30, 202617d ago 8-K Neutral 4/10 Entry $39.06 to $39.16 Now $47.22 +20.89% ▲ +0.26% +2.96% vs SPY
  3. Oct 30, 202617d ago Press Release Neutral 4/10 Entry $39.06 to $39.16 Now $47.22 +20.89% ▲ +0.26% +2.96% vs SPY
  4. Oct 7, 20265w ago 8-K Bearish 5/10 Entry $35.89 to $37.18 Now $47.22 −31.57% ▼ −3.59% −4.57% vs SPY
  5. Sep 17, 20268w ago 8-K Neutral 2/10 Entry $33.63 to $34.20 Now $47.22 +40.41% ▲ +1.69% +1.09% vs SPY
  6. Sep 4, 202610w ago 8-K Neutral 4/10 Entry $31.33 to $32.04 Now $47.22 +50.72% ▲ +2.27% +3.48% vs SPY
  7. Aug 24, 202612w ago 8-K Neutral 4/10 Entry $32.88 to $32.65 Now $47.22 +43.61% ▼ −0.70% −1.17% vs SPY
  8. Aug 8, 202614w ago Institutional Cluster Mixed 5/10 Entry $33.33 to $33.58 Now $47.22 +41.67% ▲ +0.75% +0.80% vs SPY
  9. Aug 4, 202614w ago Press Release Bullish 7/10 Entry $31.82 to $33.53 Now $47.22 +48.40% ▲ +5.37% +5.02% vs SPY
  10. Jul 8, 202618w ago 8-K Mixed 5/10 Entry $24.51 to $25.44 Now $47.22 +92.66% ▲ +3.79% +2.93% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (10h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026